Essbio S.A. reported earnings results for the third quarter and nine months ended September 30, 2022. For the third quarter, the company reported sales was CLP 48,931.51 million compared to CLP 43,255.17 million a year ago. Net loss was CLP 4,219.79 million compared to net income of CLP 3,307.24 million a year ago. Basic loss per share from continuing operations was CLP 0.16 compared to basic earnings per share from continuing operations of CLP 0.12 a year ago.
For the nine months, sales was CLP 158,209.5 million compared to CLP 137,570.6 million a year ago. Net income was CLP 4,537.14 million compared to CLP 16,060.59 million a year ago. Basic earnings per share from continuing operations was CLP 0.17 compared to CLP 0.61 a year ago.